Top Stories – Caterpillar (NYSE:CAT), General Electric (NYSE:GE) , Casella Waste (NASDAQ:CWST) , Nymox Pharmaceutical (NASDAQ:NYMX) , Rayonier (NYSE:RYN)

General Electric Company (NYSE:GE) is touting an improved natural gas fuel cell that it hopes one day will provide low-cost electricity to commercial and industrial plants, as well as allow for targeted boosts to electrical grids without the need for costly large power plants and added transmission lines. General Electric Company (NYSE:GE) stock performance was 0.15% in last session and finished the day at $26.02. Traded volume was 34.54million shares in the last session and the average volume of the stock remained 27.10million shares. The beta of the stock remained 1.49. General Electric Company (NYSE:GE) insider ownership is 0.04%.

The Wall Street Journal reports, “Caterpillar Inc. (NYSE:CAT) believes it is ‘more likely than not’ to persuade U.S. tax authorities that it complied with tax rules in pursuing a strategy that shifts profits to a Swiss subsidiary, the company said in a securities filing Monday. The filing was a response to queries from staff members at the U.S. Securities and Exchange Commission.” Caterpillar Inc. (NYSE:CAT) dropped -0.15 percent to $110.06 Tuesday on volume of 2.88million shares. The intra-day range of the stock was $109.80 to $111.28. Caterpillar Inc. (NYSE:CAT) has a market capitalization of $68.84billion.

Casella Waste Systems Inc. (NASDAQ:CWST) has reached a settlement agreement with the state, Attorney General Eric Schneiderman announced Monday. The waste hauling firm agreed to change its contract structures and pay $100,000 to New York. Casella Waste Systems Inc. (NASDAQ:CWST)’s stock on July 22, 2014 reported a increase of 1.85% to the closing price of $4.95. Its fifty two weeks range is $4.60 -$6.20. The total market capitalization recorded $198.54million. The overall volume in the last trading session was 65,580.00million shares. In its share capital, CWST has 40.10million outstanding shares.

Nymox Pharma Corporation (NASDAQ:NYMX) announces new positive efficacy data for U.S. Study NX02-0022, the Company’s repeat injection study of NX-1207 for BPH. Analysis of symptomatic improvement from repeat injection over a 1 to 2 year period showed a mean improvement of 8.2 points (p <.001) in the AUA BPH Symptom Index Score. Evaluation of safety data from this study confirmed that NX-1207 reinjection treatment was well-tolerated by patients, did not impair sexual function, and has not shown any drug-related significant side effects. On Tuesday, shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) advanced 4.12% to close the day at $5.05. Company return on investment (ROI) is 73.80% and its monthly performance is recorded as 1.81%. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) quarterly revenue growth is -1.94%.

Rayonier Inc (NYSE:RYN) announced a special dividend on Monday, July 21st, Analyst RN reports. Investors of record on Thursday, July 31st will be paid a dividend of 0.50 per share on Friday, August 15th. Rayonier Inc. (NYSE:RYN) stock performance was 0.57% in last session and finished the day at $35.44. Traded volume was 918,211.00million shares in the last session and the average volume of the stock remained 1.15million shares. The beta of the stock remained 0.80. Rayonier Inc. (NYSE:RYN) insider ownership is 0.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone